433 hasil
Menampilkan 1–20 · 0,23 detik · RSS
Polish Journal of Pathology
Scopus
ISSN 1233-9687 · Termedia Publishing House · 433 artikel di indeks
-
Artikel Jurnal
The role of computational pathology in predicting expression of selected immunohistochemical markers
Immunohistochemistry (IHC) remains a cornerstone of precision oncology, providing essential diagnostic, prognostic, and predictive molecular data. However, the traditional manual assessment of IHC slides faces persistent challenges regarding interobserver variability, reproducibility, and high…
-
Artikel Jurnal
Using large-scale tissue microarray resources for the identification and evaluation of old, new, and novel targets for surgical pathology
Immunohistochemistry (IHC) is essential in diagnostic pathology, but antibody reliability is often limited by insufficient validation and high variability between clones. Conventional validation approaches normally use only few tissues or cell lines which do not reflect tissue and cell type…
-
Artikel Jurnal
Ancillary tests in diagnostic cytology. On the example of the recommendation given by the World Health Organization in soft tissue tumors
Fine needle aspiration despite being an inexpensive, rapid, accurate and non-invasive diagnostic practice, particularly when used in oncology, is frequently underutilized. The World Health Organization – International Academy of Cytology – International Agency of Research on Cancer initiated a…
-
Artikel Jurnal
Pitfalls in the diagnosis of melanocytic tumours: is immunohistochemistry helpful?
The diagnosis and differential diagnosis of benign, intermediate and malignant melanocytic neoplasms remain a recurring and clinically important challenge in dermatopathology. The difficulty is not limited to rare melanoma variants, it also includes non-melanocytic lesions that simulate melanocytic…
-
Artikel Jurnal
Generation of virtual stains - can AI imitate chemistry?
Histological staining is the foundation of anatomic pathology, yet traditional wet-lab workflows are slow, consume irreplaceable tissue, and are prone to artifactual variability. As precision oncology increasingly demands comprehensive molecular testing from limited biopsy samples, conserving…
-
Artikel Jurnal
Challenging cases of Epstein-Barr virus positive lymphomas
Epstein-Barr virus (EBV)-associated lymphomas can develop in both immuno- competent and immunocompromised patients, such as those with human immunodeficiency virus (HIV) infection, other primary or acquired immunodeficiencies, or post transplantation. The current World Health Organization…
-
Artikel Jurnal
Immunohistochemistry in the differential diagnosis of cutaneous spindle cell neoplasms
Cutaneous spindle cell neoplasms may cause considerable problems in the diagnosis and proper treatment of affected patients. After exclusion of nonmesenchymal spindle cell lesions, including /spindle cell (sarcomatoid) carcinoma as well as spindle cell and desmoplastic melanoma, the line of…
-
Artikel Jurnal
Review of a Decade of IHC Quality – Expectations, Disappointments and Challenges in Commonly Used Assays Based on NordiQC Experience
Immunohistochemistry (IHC) has undergone substantial expansion during the past decades, with an increasing number of assays becoming essential to routine diagnostic, prognostic, and predictive pathology. Parallel to this development, external quality assessment (EQA) programs have accumulated…
-
Artikel Jurnal
New technologies in the genomic evaluation of lymphomas
Lymphomas represent a heterogenous group of lymphoid neoplasms with a broad spectrum of clinical presentations and challenges in therapy resistance and relapse. Response to treatment and prognosis vary between and within lymphoma subtypes. The introduction of high-throughput molecular profiling…
-
Artikel Jurnal
Immunohistochemistry in placental pathology
Although the clinical background, gross and hematoxylin-eosin examination usually suffice for the placental diagnosis, immunohistochemistry (IHC) is essential in many cases, particularly in high-risk pregnancy. The double E-cadherin/CD34 immuno-stain is the backbone of it, particularly for…
-
Artikel Jurnal
New and emerging entities of uterine mesenchymal tumours in the era of molecular testing
Uterine mesenchymal tumours represent a group of heterogeneous tumours, the classification of which is evolving, especially in the context of a broader use of molecular testing. Some entities can be diagnosed based on the combination of morphological and immunohistochemical features. In other…
-
Artikel Jurnal
p16/Ki-67 dual-stain immunocytochemistry in precision cervical cancer prevention: immunoprofile and clinical decision-making
Cervical cancer prevention has undergone a major shift with the implementation of human papillomavirus (HPV)-based screening, which offers high sensitivity but limited specificity due to the detection of transient infections. This has created a need for triage methods capable of identifying…
-
Artikel Jurnal
Immunohistochemical and molecular diagnostics tailoring personalised ovarian cancer therapy
Ovarian cancer remains the most lethal gynaecological malignancy, and it exhibits substantial histologic and molecular heterogeneity. Traditional systemic therapies have produced only modest survival gains. Integration of immunohistochemical (IHC) and molecular diagnostics has shifted care toward…
-
Artikel Jurnal
Towards standardized categorization of serous effusions: application of the International System for Reporting Serous Fluid Cytopathology diagnostic framework with a special emphasis on borderline ovarian tumors
Borderline ovarian tumors (BOT) in effusion cytology are rare, and to date only limited literature has existed. The current study used the International System for Reporting Fluid Cytopathology (ISRSFC) criteria to reclassify 321 effusion cytology cases from 302 patients, analyzed diagnostic…
-
Artikel Jurnal
CMTM6: a potential biomarker in non-small cell lung carcinoma
Lung cancer is the most common cause of cancer-related deaths worldwide. With the advent of immunotherapy, programmed cell death-1 and programmed death ligand 1 (PD-L1) inhibitors have gained clinical importance, driving research into their regulatory mechanisms. CKLF-like MARVEL transmembrane…
-
Artikel Jurnal
Utility of BRAF immunohistochemistry for the detection of BRAF mutations in papillary thyroid carcinoma. Analysis of detailed histological subtypes
The BRAF mutation has been observed in 32–73% of papillary thyroid carcinomas. Despite the superiority of genetic tests for detecting BRAF mutations, they have inherent disadvantages. The objective of this study was to analyze the specificity and sensitivity of BRAF immunohistochemistry (IHC) that…
-
Artikel Jurnal
Diagnostic consistency of programmed death-ligand 1 immunohistochemistry – comparative analysis of SP142 and 22C3 clones in non-small cell lung cancer
Programmed death-ligand 1 (PD-L1) expression is a critical predictive biomarker for immune checkpoint inhibitor therapies in non-small cell lung cancer (NSCLC). Although various antibody clones are used for immunohistochemical (IHC) detection, differences in platforms and scoring algorithms raise…
-
Artikel Jurnal
Pulmonary granular cell tumor coexisting with interstitial lung disease – a rare case report
A granular cell tumor (GCT) is a soft tissue neoplasm of rare occurrence in the lung. A 44-year-old male asphalt worker had interstitial lung disease. Incidentally, a 7 mm polypoid nodule was observed at the entrance of the right upper lobe bronchus. Tumor cells were characterized by a large…